Is NHKFF or MRK a better dividend investment in 2026?

NHKFF currently yields 557.10% with a 5% 5-year dividend growth rate. MRK yields 2.76% with 8.2% growth. The better choice depends on your goal: NHKFF offers higher current income.

What is the dividend yield difference between NHKFF and MRK?

NHKFF has a forward dividend yield of 557.10% ($2.00/share annually). MRK yields 2.76% ($3.32/share annually). The yield gap is 554.34 percentage points.

Home › Compare › NHKFF vs MRK

NHKFF vs MRK: Dividend Comparison 2026

NHKFF yields 557.10% · MRK yields 2.76%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 NHKFF wins by $174318500157098033152.00M in total portfolio value

INVESTMENT

TIME HORIZON10 years

NHKFF

● Live price

557.10%

Share price

$0.36

Annual div

$2.00

5Y div CAGR

95.5%

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$174318500157098033152.00M

Annual income

$174,243,062,167,289,250,000,000,000.00

Full NHKFF calculator →

MRK

Merck & Co. Inc.

● Live price

2.76%

Share price

$120.31

Annual div

$3.32

5Y div CAGR

32.7%

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$56.8K

Annual income

$9,798.13

Full MRK calculator →

Portfolio growth — NHKFF vs MRK

📍 NHKFF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	NHKFF	MRK
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, NHKFF + MRK cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

NHKFF pays

MRK pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

NHKFF

Annual income on $10K today (after 15% tax)

$47,353.76/yr

After 10yr DRIP, annual income (after tax)

$148,106,602,842,195,860,000,000,000.00/yr

MRK

Annual income on $10K today (after 15% tax)

$234.56/yr

After 10yr DRIP, annual income (after tax)

$8,328.41/yr

At 15% tax rate, NHKFF beats the other by $148,106,602,842,195,860,000,000,000.00/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of NHKFF + MRK for your $10,000?

NHKFF: 50%MRK: 50%

100% MRK50/50100% NHKFF

Portfolio after 10yr

$87159250078549016576.00M

Annual income

$87,121,531,083,644,620,000,000,000.00/yr

Blended yield

99.96%

📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

NHKFF

No analyst data

MRK

Analyst Ratings

Buy

Hold

Sell

Consensus: Buy

Price Target

$128.54

+6.8% upside vs current

Range: $100.00 — $150.00

Altman Z

4.0

Piotroski

6/9

Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

NHKFF buys

MRK buys

No recent congressional trades found for NHKFF or MRK in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricNHKFFMRK

Forward yield	557.10% ✓	2.76%
Annual dividend / share	$2.00	$3.32 ✓
Payout ratio	50%	50%
1-year div growth	0%	0%
5-year div CAGR	95.5% ✓	32.7%
Portfolio after 10y	$174318500157098033152.00M ✓	$56.8K
Annual income after 10y	$174,243,062,167,289,250,000,000,000.00 ✓	$9,798.13
Total dividends collected	$174313561310925258752.00M ✓	$28.9K
Payment frequency	quarterly	quarterly
Sector	Stock	Healthcare

Year-by-year: NHKFF vs MRK ($10,000, DRIP)

Year	NHKFF Portfolio	NHKFF Income/yr	MRK Portfolio	MRK Income/yr	Gap
1← crossover	$119,614	$108,913.65	$11,206	$366.19	+$108.4K → NHKFF
2	$2,508,256	$2,380,268.96	$12,650	$502.35	+$2.50M → NHKFF
3	$93,880,730	$91,196,896.77	$14,407	$694.19	+$93.87M → NHKFF
4	$6,337,049,933	$6,236,597,552.02	$16,585	$967.82	+$6337.03M → NHKFF
5	$775,948,938,114	$769,168,294,685.67	$19,342	$1,363.89	+$775948.92M → NHKFF
6	$172,910,255,380,782	$172,079,990,016,999.80	$22,913	$1,947.19	+$172910255.36M → NHKFF
7	$70,246,761,459,188,210	$70,061,747,485,930,776.00	$27,662	$2,823.89	+$70246761459.16M → NHKFF
8	$52,080,691,335,612,070,000	$52,005,527,300,850,740,000.00	$34,159	$4,173.35	+$52080691335612.04M → NHKFF
9	$70,502,794,213,834,740,000,000	$70,447,067,874,105,630,000,000.00	$43,337	$6,308.80	+$70502794213834736.00M → NHKFF
10	$174,318,500,157,098,050,000,000,000	$174,243,062,167,289,250,000,000,000.00	$56,776	$9,798.13	+$174318500157098033152.00M → NHKFF

NHKFF vs MRK: Complete Analysis 2026

NHKFF — Stock

Nichi-Iko Pharmaceutical Co., Ltd. manufactures, sells, and distributes various pharmaceutical products. It operates through two segments, Nichi-Iko Group and Sagent Group. The company primarily focuses on the production of generic drugs. It offers antidiabetic agents, antacids, antireflux agents, beta-blocker, hypnotic and sedative, angiotensin ? antagonist, angiotensin ? antagonist/diuretic combination, dyslipidaemic agent, and calcium antagonist products, as well as chemotherapeutic agents. The company also provides treatments for circulatory, digestive, respiratory, nervous system, allergies, and others. It supplies its products to medical institutions, including hospitals, clinics, dispensing pharmacies, etc. The company was formerly known as Nihon Iyakuhin Kogyo Co., Ltd. and changed its name to Nichi-Iko Pharmaceutical Co., Ltd. in 2005. Nichi-Iko Pharmaceutical Co., Ltd. was incorporated in 1947 and is headquartered in Toyama, Japan.

Full NHKFF Calculator →

MRK — Healthcare

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.

Full MRK Calculator →

📬

Get this NHKFF vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

NHKFF vs SCHD NHKFF vs JEPI NHKFF vs O NHKFF vs KO NHKFF vs MAIN NHKFF vs JNJ NHKFF vs ABBV NHKFF vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.